Mitomycin Patent Expiration

Mitomycin was first introduced by Bristol Laboratories Inc Div Bristol Myers Co in its drug Mutamycin on Approved Prior to Jan 1, 1982. Other drugs containing Mitomycin are Mitosol, Jelmyto, Mitozytrex. 13 different companies have introduced drugs containing Mitomycin.


Mitomycin Patents

Given below is the list of patents protecting Mitomycin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Jelmyto US9040074 Material and method for treating internal cavities Jan 20, 2031 Urogen Pharma
Jelmyto US9950069 Material and method for treating internal cavities Jan 20, 2031 Urogen Pharma
Mitosol US7806265 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Feb 01, 2029 Mobius Therap
Mitosol US8186511 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Jul 19, 2026 Mobius Therap
Mitosol US9205075 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Jul 19, 2026 Mobius Therap
Mitosol US9539241 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Jan 02, 2028 Mobius Therap
Mitosol US9649428 Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application May 21, 2029 Mobius Therap


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Mitomycin Generics

Several generic applications have been filed for Mitomycin. The first generic version for Mitomycin was by Bristol Myers Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Fresenius Kabi Usa Llc and was approved on Apr 5, 2024.

Given below is the list of companies who have filed for Mitomycin generic.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG/VIAL

(reference standard)

injectable Prescription INJECTION AP Apr 30, 1998
20MG/VIAL

(reference standard)

injectable Prescription INJECTION AP Apr 30, 1998
40MG/VIAL

(reference standard)

injectable Prescription INJECTION AP Aug 11, 2009


2. BRISTOL MYERS

Bristol Myers Co has filed for 3 different strengths of generic version for Mitomycin. All of these versions come by the name MUTAMYCIN. Given below are the details of the strengths of this generic introduced by Bristol Myers.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG/VIAL injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
5MG/VIAL injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** injectable Discontinued INJECTION N/A Mar 10, 1988


3. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG/VIAL injectable Prescription INJECTION AP Dec 23, 1999
20MG/VIAL injectable Prescription INJECTION AP Dec 23, 1999
40MG/VIAL injectable Prescription INJECTION AP Jun 2, 1999


4. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG/VIAL injectable Prescription INJECTION AP Oct 20, 2021
5MG/VIAL injectable Prescription INJECTION AP Oct 20, 2021
40MG/VIAL injectable Prescription INJECTION AP Nov 22, 2022


5. HOSPIRA

Hospira Inc has filed for 1 generic for Mitomycin. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG/VIAL injectable Discontinued INJECTION N/A Nov 29, 1995


6. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/VIAL injectable Prescription INJECTION AP Sep 6, 2022
5MG/VIAL injectable Prescription INJECTION AP Sep 8, 2022
20MG/VIAL injectable Prescription INJECTION AP Sep 8, 2022


7. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/VIAL injectable Prescription INJECTION AP Oct 30, 2023
5MG/VIAL injectable Prescription INJECTION AP Oct 30, 2023
20MG/VIAL injectable Prescription INJECTION AP Oct 30, 2023


8. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG/VIAL injectable Prescription INJECTION AP Apr 5, 2024
40MG/VIAL injectable Prescription INJECTION AP Apr 5, 2024
20MG/VIAL injectable Prescription INJECTION AP Apr 5, 2024


9. RK PHARMA

Rk Pharma Inc has filed for 3 different strengths of generic version for Mitomycin. Given below are the details of the strengths of this generic introduced by Rk Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG/VIAL injectable Prescription INJECTION AP Oct 13, 2017
20MG/VIAL injectable Prescription INJECTION AP Oct 13, 2017
40MG/VIAL injectable Prescription INJECTION AP Oct 13, 2017